Drug search by name

Lorcaserin Extended-Release Tablets and Pulmonary hypertension

Result of checking the interaction of drug Lorcaserin Extended-Release Tablets and disease Pulmonary hypertension for safety when used together.

Check result:

Lorcaserin Extended-Release Tablets <> Pulmonary hypertension

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Lorcaserin is believed to promote satiety by selectively activating serotonin 2C receptors on anorexigenic pro-opiomelanocortin neurons located in the hypothalamus. Certain centrally-acting weight loss agents that act on the serotonin system have been associated with pulmonary hypertension, a rare but lethal disease. Care should be taken when prescribing this drug to patients at risk or with pulmonary hypertension.

Lorcaserin Extended-Release Tablets

Generic Name: lorcaserin

Brand Name: Belviq, Belviq XR

Synonyms: Lorcaserin

What is Lorcaserin Extended-Release Tablets?